Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02795312 · ClinicalTrials.gov registry record · NA

Mindfulness Based Smoking Cessation Program

A NA study of Cancer and Smoking Cessation, sponsored by Boston Medical Center.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT02795312 is a NA study of Cancer and Smoking Cessation that has completed, run by Boston Medical Center. The registered enrollment target is 18 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02795312, a NA study of Cancer and Smoking Cessation, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

This is a study designed to mindfulness based stress reduction (MBSR) training program to assess feasibility and acceptability of the intervention. Participants will participate in a 9-week training program and complete pre-and post-questionnaires. Participants will have the option of participating in a follow-up focus group.

Conditions Studied

Interventions

  • BEHAVIORAL Smoking Cessation Program

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2016-07
Est. Completion 2018-03
Phase NA

Sponsor

Boston Medical Center

253 total trials

What the Registry Record Tells You About NCT02795312

The ClinicalTrials.gov registry entry for NCT02795312 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Smoking Cessation Program is the first listed.

NCT02795312 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02795312 about?

NCT02795312 is a clinical study titled "Mindfulness Based Smoking Cessation Program". This is a study designed to mindfulness based stress reduction (MBSR) training program to assess feasibility and acceptability of the intervention. Participants will participate in a 9-week training program and complete pre-and post-questionnaires. Participants will have the option of participating ...

What is the current status of trial NCT02795312?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2016-07. Estimated completion is 2018-03.

What conditions does trial NCT02795312 study?

This clinical trial studies the following conditions: Cancer, Smoking Cessation.

What interventions are being tested in trial NCT02795312?

The interventions under investigation include: Smoking Cessation Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02795312?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02795312 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.